10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001213900-15-008265`
Period End Date	20150930
Filing Date	20151106
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	relm-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 18 Cash Flow Statement 51

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$884.92K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.05M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.91K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$22.27K	USD	Point-in-time
Other assets	`OtherAssets`	$411.88K	USD	Point-in-time
Other assets	`OtherAssets`	$400.82K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	11.01M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.78M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	11.01M	shares	Point-in-time
Total assets	`Assets`	$20.48M	USD	Point-in-time
Total assets	`Assets`	$24.39M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.78M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$835.28K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$482.27K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$614.53K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$263.75K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$176.45K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$14.00M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.71M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.58M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 11,014,155 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$10.78K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 11,014,155 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$11.01K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$85.28M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.84M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$24.39M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.48M	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$718.97K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.76M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.72M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.63M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.72M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$9.29M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-26.11M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.04K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.12K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.64K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.27K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-26.12M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$9.29M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$4.66M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-29.84M	USD	1 Quarter

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$4.66M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-29.84M	USD	1 Quarter
Depreciation expense	`Depreciation`	$2.95K	USD	1 Quarter
Depreciation expense	`Depreciation`	$3.59K	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	$-875.00K	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	$-78.92K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$283.50K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$157.99K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$26.11M	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-9.29M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-601.93K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$11.06K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$314.71K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-121.36K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$497.47K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$132.26K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.22M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.32M	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$10.67K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$1.31K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.31K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.67K	USD	1 Quarter
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$4.31M	USD	1 Quarter
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$87.30K	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$148.44K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.16M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-87.30K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$1.83M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$-3.30M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$19.17M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	$3.27K	USD	1 Quarter
Interest	`InterestPaid`	$1.64K	USD	1 Quarter
Issuance of common stock resulting from cashless exercise of warrants	`IssuanceOfCommonStockResultingFromCashlessExerciseOfWarrants`	$220.00	USD	1 Quarter
Issuance of common stock resulting from cashless exercise of warrants	`IssuanceOfCommonStockResultingFromCashlessExerciseOfWarrants`	-	USD	1 Quarter
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$263.80K	USD	Point-in-time
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.62K	USD	1 Quarter
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	-	USD	1 Quarter
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	$55.22K	USD	1 Quarter
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	-	USD	1 Quarter
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	$4.88M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.